Parameter | 1-year survival rate (%) | Median survival time (days) | P value |
---|---|---|---|
Total | 58.3 | 398 | Â |
Age | Â | Â | Â |
   >=60y | 71.4 | 476 |  |
   < 60y | 50 | 213 | 0.4159 |
Sex | Â | Â | Â |
   Male | 66.7 | 476 |  |
   Female | 0 | 282 | 0.4797 |
Performance status | Â | Â | Â |
   0-1 | 100 | 834 |  |
   2 | 0 | 112 | 0.0004 |
Treatment line | Â | Â | Â |
   ~2nd | 72.9 | 834 |  |
   3rd~ | 42.9 | 112 | 0.0629 |
Reaction at injection site | Â | Â | Â |
   Strong | 75.0 | 476 |  |
   Weak | 50.9 | 398 | 0.5207 |
CTL | Â | Â | Â |
   Strong | 85.7 | - |  |
   Weak | 33.3 | 112 | 0.0176 |
Regulatory T (%) | Â | Â | Â |
   High | 57.1 | 476 |  |
   Low | 33.3 | 282 | 0.3856 |
C-reactive protein | Â | Â | Â |
   >=1.0 | 25.0 | 53 |  |
   < 1.0 | 71.6 | 834 | 0.0284 |
Hemoglobin | Â | Â | Â |
   Normal | 57.1 | 834 |  |
   Low | 56.3 | 398 | 0.891 |
Albumin | Â | Â | Â |
   Normal | 57.1 | 834 |  |
   Low | 62.5 | 398 | 0.8256 |
White blood cell count | Â | Â | Â |
   High | 55.6 | - |  |
   Normal | 66.7 | 398 | 0.7070 |
Neutrophile (%) | Â | Â | Â |
   High | 75.0 | 834 |  |
   Low | 38.1 | 282 | 0.1902 |
Lymphocyte (%) | Â | Â | Â |
   High | 50.0 | 282 |  |
   Low | 66.7 | 398 | 0.5006 |